10x Genomics launches international cancer research project
Life sciences company 10x Genomics has launched an initiative to create a pan-cancer spatial atlas driven by spatial research in the Asia-Pacific region.
As part of the initiative, 10x Genomics has partnered with the Garvan Institute of Medical Research in Australia and the University of Tokyo in Japan to create the Asia-Pacific Spatial Translational Research Alliance (ASTRA). The consortium will unite spatial research across the Asia-Pacific region, using 10x Genomics’ Xenium spatial platform to map how cancer and immune cells communicate across 2,000 tumour samples.
ASTRA, led by Dr Ankur Sharma of the Garvan Institute and Dr Yutaka Suzuki of the University of Tokyo, will bring together cancer researchers, clinicians and data scientists to study ten major cancer types using custom Xenium panels tailored to specific tissues. The consortium will power research on molecular and spatial data across cancer types.
“This is the latest large-scale international research initiative powered by 10x,” said Ben Hindson, Co-Founder and Chief Scientific Officer of 10x Genomics.
“We’re thrilled to be a part of this ambitious, multi-country effort to chart the cellular complexity of cancer.
“Projects like ASTRA show how spatial biology connects researchers across borders and helps translate cellular insight into treatments that reflect global patient diversity.”
Powering cross-border cancer research
The project will identify immune interactions and molecular features that differ across populations, building a shared reference for cancer biology that informs both local and global therapeutic development.
The resulting atlas will serve as a shared foundation for precision oncology in Asia-Pacific, linking cellular context, genetic diversity and population-scale insights that have been underrepresented in global cancer data.
ASTRA will also expand participation to include additional partners across the broader Asia-Pacific region, establishing new regional spatial biology hubs and digital infrastructure for data sharing. The effort will also address logistical barriers such as biospecimen movement and data harmonisation to ensure high-quality, cross-border collaboration.
“ASTRA represents a new model for scientific collaboration – agile, distributed and deeply connected to the healthcare needs of the Asia-Pacific region,” said Dr Ankur Sharma, Laboratory Head at the Garvan Institute of Medical Research.
“By combining our expertise and leveraging 10x’s cutting-edge Xenium spatial technology, we aim to build the most comprehensive cancer atlas for our part of the world.”
“ASTRA represents a powerful step toward global equity in cancer research,” added Dr Yutaka Suzuki, Professor at the University of Tokyo.
“By uniting leading researchers across the Asia-Pacific and leveraging 10x Genomics’ Xenium technology, we can capture the cellular complexity of cancer in our populations and build a shared foundation for truly personalised medicine.”
Bruno Quinney, Content Team, DDW
